Perform Reimbursable Point-of-care Diabetic Eye Exams
AEYE-DS allows for diabetic retinopathy screenings to be done in primary care settings, eliminating the need for referral to specialists and increasing efficiency with AI technology that is FDA-cleared.
How it works
Imaging
is performed using the fully automated camera
Analysis
is performed by the AI in under a minute
Diagnosis
is produced along with a PDF report
_edited.png)
_edited.png)
_edited.png)
_edited.png)
_edited.png)
Perfect for Primary Care Settings
The procedure can be performed by any healthcare staff, with no prior knowledge or experience required
The procedure is reimbursable using CPT code 92229 for point-of-care automated analysis and report
Improves quality measures and closes care gaps with HEDIS compliant annual diabetic eye exams
No lock-in monthly subscription for both the Topcon retinal camera and diagnostic AI
Why It Matters
Screening prevents blindness
Accessible and affordable screening for Diabetic Retinopathy is vital to help ensure diabetics receive sight-saving treatment.
Before
After
Before
About AEYE Health
We are dedicated to preventing blindness through accessible, accurate, and affordable diagnostic screening solutions that address care gaps in primary care.
Our AI expertise in retinal imaging has led to the development of AEYE-DS
Watch our company Video
